REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gi Innovation Inc. (South Korea)

Main Activities: Scientific Research and Development Services
Full name: Gi Innovation Inc. Profile Updated: July 04, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Gi Innovation Inc. is engaged in provision of researches and develops innovative protein new drugs through well-structured translational research. The company was incorporated in 2017 and is based in Seoul, South Korea.

Headquarters
A-dong, 1116-ho, 167, Songpa-daero Songpa-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Gi Innovation Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Gi Innovation Inc. report to view the information.
Outstanding Shares:
Purchase the Gi Innovation Inc. report to view the information.
Registered Capital:
Purchase the Gi Innovation Inc. report to view the information.
Incorporation Date:
July 19, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Company Performance
Financial values in the chart are available after Gi Innovation Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-37.5%▼
Total operating revenue
-37.5%▼
Operating profit (EBIT)
-121.83%▼
EBITDA
-127.47%▼
Net Profit (Loss) for the Period
47.04%▲
Total assets
-40.88%▼
Total equity
-43.88%▼
Operating Profit Margin (ROS)
-1394.49%▼
Net Profit Margin
410.88%▲
Return on Equity (ROE)
4.98%▲
Debt to Equity Ratio
1.5%▲
Quick Ratio
-14.61%▼
Cash Ratio
-0.97%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo